A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.


Updates from The Motley Fool

Latest updates on DepoMed from Fool.com.  The Fool has written over 100 articles on DepoMed.
Why DepoMed is Falling 10% Today

A crack-down on buying, repricing, and relaunching previously approved drugs is weighing on DepoM...



Stock Performance

View Interactive DEPO Charts
Sponsored by

Key Data Points

Primary metrics and data points about DepoMed.
Current Price: $7.86
Prev Close: $8.15
Open: $8.18
Bid: $7.84
Ask: $7.85
Day's Range: $7.53 - $8.25
52wk Range: $4.31 - $18.77
Volume: 1,097,503
Avg Vol 1,463,580
Market Cap: $495M
P/E (ttm): -4.45
EPS (ttm): ($1.83)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about DepoMed.
CAPS Rating 3 out of 5
 
257 Outperform
15 Underperform
CAPS All Stars
 
35 Outperform
2 Underperform

How do you think DepoMed will perform against the market?



You pick for DepoMed is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Arthur Higgins, CEO

19% Approve

Based on 6 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for DepoMed.

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers